on global viral inactivation market is an in depth analysis of the segments and
sub-segments in the viral inactivation market. The report provides analysis for
the global as well as regional markets over the period of 2015 to 2023. According
to report the global viral inactivation market is expected to grow at a CAGR of
10.9% over the forecast period of 2017 - 2023.
Figure 1: Global Viral Inactivation Market by Value 2015– 2023
on global viral inactivation market covers segments such as method, product,
application, and end user. The method segments include solvent detergent
method, pasteurization and other methods. On the basis of product, the global
viral inactivation market is categorized into kits and reagents, services and
viral inactivation systems and accessories. Furthermore,
on the basis of application the viral inactivation market is segmented as,
vaccines and therapeutics, blood and blood products, cellular and gene therapy
products, tissues and tissue products, and stem cell products. On the basis of
end user the viral inactivation market is segmented as pharmaceutical and
biotechnology companies, contract research organizations, academic research
institutes, and other end users.
report provides regional analysis covering geographies such as North America,
Europe, Asia-Pacific, and Rest of the World. In this section the key trends and
market size for each geography is provided over the period of 2015 – 2023.
Figure 2: Global Viral Inactivation Market by Region, CAGR %,
countries covered in the North America region include the U.S., Canada, and
Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia
and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe
are included in the European region. The U.S. drives the growth in the North
America region as it is the largest market in the region. The Asia-pacific
region offers a substantial potential for the market growth owing to rapid
growth in markets such as India and China. The APAC region is projected
to experience a growth at a CAGR of x.x% over the period of 2017 - 2023.
report provides profiles of the companies in the global viral inactivation
market such as, Clean Cells Inc., Merck KGAA, Viral Inactivated Plasma Systems
SA, Sartorius AG, Charles River Laboratories International, Inc., Rad Source
Technologies, Inc., Wuxi Pharmatech (Cayman) Inc., Texcell, Inc., Parker
Hannifin Corporation, and Danaher Corporation.
report provides deep insights on demand forecasts, market trends and micro and
macro indicators. In addition, this report provides insights on the factors
that are driving and restraining the Global Viral Inactivation Market. Moreover,
IGR-Growth Matrix analysis given in the report brings an insight on the
investment areas that existing or new market players can consider.
report provides insights into the market using analytical tools such as
Porter’s five forces analysis and DRO analysis of Viral Inactivation Market.
Moreover, the study highlights current market trends and provides forecast from
2017 to 2023. We also have highlighted future trends in the Viral Inactivation
Market that will impact the demand during the forecast period. Moreover, the
competitive analysis given in each regional market brings an insight on the
market share of the leading players. Additionally, the analysis highlights rise
and fall in the market shares of the key players in the market.
report will help manufacturers, suppliers and distributors of the Viral
Inactivation Market to understand the present and future trends in this market
and formulate their strategies accordingly.